Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H11NO2 |
Molecular Weight | 165.1891 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)C1=CC(N)=CC=C1
InChI
InChIKey=ZMCBYSBVJIMENC-UHFFFAOYSA-N
InChI=1S/C9H11NO2/c1-2-12-9(11)7-4-3-5-8(10)6-7/h3-6H,2,10H2,1H3
Molecular Formula | C9H11NO2 |
Molecular Weight | 165.1891 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16129913Curator's Comment: description was created based on several sources, including
https://www.drugs.com/pro/tricaine-s.html | https://www.ncbi.nlm.nih.gov/pubmed/25090007 | https://www.ncbi.nlm.nih.gov/pubmed/6278838
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16129913
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/pro/tricaine-s.html | https://www.ncbi.nlm.nih.gov/pubmed/25090007 | https://www.ncbi.nlm.nih.gov/pubmed/6278838
Tricaine (MS-222, Tricaine-S), a water-soluble local anesthetic, is used commonly for sedation, immobilization, and anesthesia of poikilothermic animals and has been accepted as a common anesthetic for use in the cold-blooded animals. It has long been recognized as a valuable tool for the proper handling of these animals during manual spawning (fish stripping), weighing, measuring, marking, surgical operations, transport, photography, and research. Tricaine was developed by Merck as a sulfonated analog of benzocaine with high solubility in water. The main advantage of Tricaine is the short duration of action and rapid metabolism. There are many reports describing the use of Tricaine for anesthetizing poikilothermic animals because it is a safe agent for immersion anesthesia even though the other anesthetics such as ether, ethanol, thiopental, halothane, isoflurane, barbiturates also could be used. Amphibians could be anesthetized easily by immersion methods with Tricaine because the amphibian skin is extremely permeable and water is absorbed through the skin rather than ingested. Tricaine has been administered as an injectable agent also.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2331043 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25090007 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16129913 |
Primary | Unknown Approved UseUnknown |
Doses
Dose | Population | Adverse events |
---|---|---|
0.05 % 1 times / day multiple, topical Recommended Dose: 0.05 %, 1 times / day Route: topical Route: multiple Dose: 0.05 %, 1 times / day Sources: |
healthy, 62 years n = 1 Health Status: healthy Age Group: 62 years Sex: M Population Size: 1 Sources: |
Disc. AE: Vision decreased, Photophobia... AEs leading to discontinuation/dose reduction: Vision decreased Sources: Photophobia Photopsia |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Photophobia | Disc. AE | 0.05 % 1 times / day multiple, topical Recommended Dose: 0.05 %, 1 times / day Route: topical Route: multiple Dose: 0.05 %, 1 times / day Sources: |
healthy, 62 years n = 1 Health Status: healthy Age Group: 62 years Sex: M Population Size: 1 Sources: |
Photopsia | Disc. AE | 0.05 % 1 times / day multiple, topical Recommended Dose: 0.05 %, 1 times / day Route: topical Route: multiple Dose: 0.05 %, 1 times / day Sources: |
healthy, 62 years n = 1 Health Status: healthy Age Group: 62 years Sex: M Population Size: 1 Sources: |
Vision decreased | Disc. AE | 0.05 % 1 times / day multiple, topical Recommended Dose: 0.05 %, 1 times / day Route: topical Route: multiple Dose: 0.05 %, 1 times / day Sources: |
healthy, 62 years n = 1 Health Status: healthy Age Group: 62 years Sex: M Population Size: 1 Sources: |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16129913
Leopard frogs required 100–250 mg/kg of MS-222 intracoelomically, and bullfrogs were anesthetized with 250–400 mg/kg of MS-222 intracoelomically.
Larvae can be anesthetized with 50 mg/l, and adult frogs and salamanders require 200–300 mg/l.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25090007
Fish larvae were subjected electrical stimulation at room temperature using a custom-built electric stimulation set-up. Chambers with electrodes were filled with 2% agarose gel, such that the silver electrodes are completely within the gel. A circular well of volume 0.5 mL was created by removing the agarose in the centre of the chamber between the two electrodes. Fish are placed carefully into the well with desired orientation. Care was taken not to expose the electrodes to the fish swimming in the well. The electrodes are connected to a stimulator (Grass S-88, Grass Instruments, U.S.A) that generated square wave pulse trains of indicated lengths. Polarity of electrodes was reversed between pulse trains to avoid electrolysis. A range of stimulation regimes was tested, with the aim of attaining a brief twitch response, and all experiments shown used a train of 200 20 V pulses, with 0.5 ms pulse duration (100 ms total train duration) once every 5 seconds. Fish were measured before tricaine exposure, after exposure to 0.61 mM tricaine for 30 min and after #30 minutes of tricaine washout into fish water.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:39:47 GMT 2023
by
admin
on
Fri Dec 15 15:39:47 GMT 2023
|
Record UNII |
02591PHL19
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1370418
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | RxNorm | ||
|
02591PHL19
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
582-33-2
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
209-482-9
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
C003636
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
39593
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
300000023720
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
DB11552
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
Tricaine
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
C84658
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
02591PHL19
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
11400
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY | |||
|
DTXSID1044011
Created by
admin on Fri Dec 15 15:39:47 GMT 2023 , Edited by admin on Fri Dec 15 15:39:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |